trial · primary record
ANG003 Dose A
Exocrine Pancreatic Insufficiency (EPI)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 113 |
| Primary completion | 2027-07 |
| Primary endpoint | Adverse events (AEs); Treatment-emergent AEs; Serious AEs; Discontinuation due to AEs; Clinical laboratory values |
| Registry ID | NCT07450547 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:40.998Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07450547
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.